CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 156 filers reported holding CLOVIS ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $138,000 | -88.1% | 23,732 | -85.6% | 0.01% | -88.7% |
| Q1 2021 | $1,156,000 | +636.3% | 164,711 | +1458.7% | 0.11% | +657.1% |
| Q2 2019 | $157,000 | -42.7% | 10,567 | -4.2% | 0.01% | -26.3% |
| Q1 2019 | $274,000 | -90.9% | 11,031 | -80.7% | 0.02% | -91.0% |
| Q1 2018 | $3,012,000 | +427.5% | 57,054 | +835.3% | 0.21% | +34.6% |
| Q2 2017 | $571,000 | -34.4% | 6,100 | -74.8% | 0.16% | -19.6% |
| Q3 2016 | $871,000 | -72.5% | 24,159 | -73.3% | 0.19% | -30.5% |
| Q4 2015 | $3,170,000 | +412.9% | 90,561 | +987.2% | 0.28% | +342.9% |
| Q1 2015 | $618,000 | – | 8,330 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |